🇺🇸 FDA
Pipeline program

methotrexate

199/11873

Phase 3 small_molecule completed

Quick answer

methotrexate for Liver Cirrhosis, Biliary is a Phase 3 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Liver Cirrhosis, Biliary
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials